January 24, 2020
The Ministry of Health, Labor and Welfare (MHLW) approved an array of new drugs on January 23, including Japan Tobacco’s Corectim Ointment (delgocitinib), the world’s first topical JAK inhibitor, for atopic dermatitis, with their NHI price listing expected in April...read more